Characterization and relative response factor determination of process related impurity in Naproxen by nuclear magnetic resonance spectroscopy

Journal of Pharmaceutical and Biomedical Analysis

Volumn 56, Issue 3, 2011, Pages 484-490

  Iqbal, Md Yakub ^a   Rao, K M V Narayana ^a   Sridhar, G ^a   Raju, P Padmanabha ^a   Deshpande, Girish R ^a   Babu, J Moses ^a  

^a DR REDDY'S LABORATORIES LTD   (India)

Author keywords

Acrylic acid impurity; Characterization; Naproxen; RRF; Spectroscopy

Indexed keywords

ACRYLIC ACID DERIVATIVE; NAPROXEN;

ARTICLE; DRUG IMPURITY; DRUG STRUCTURE; DRUG SYNTHESIS; FRAGMENTATION REACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PROTON TRANSPORT;

ACRYLATES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CONTAMINATION; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; NAPROXEN;

EID: 79961125979     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.06.003     Document Type: Article

References (18)

1. Boynton C.S., Dick C.F., Mayor G. NSAIDs: an overview. J. Clin. Pharmacol. 1988, 28:512-517.
2. Paulus H.E., Furst D.E., Drogmoole S.H. Drugs for Rheumatic Disease 1987, Churchill Livingstone, New York, pp. 347-363.
3. Patricia C.D., Mariano D.B., Alejandro C.O. Direct and simultaneous spectrofluorometric determination of naproxen and salicylate in human serum assisted by chemometric analysis. Anal. Chim. Acta 2002, 471:87-96.
4. Osiri M., Moreland L.W. Specific cyclooxygenase 2 inhibitors: a new choice of nonsteroidal anti-inflammatory drug therapy. Arthritis Care Res. 1999, 12:351-362.
5. Li J.J., Norton M.B., Reinhard E.J., Anderson G.D., Gregory S.A., Isakson P.C., Koboldt C.M., Masferrer J.L., Perkins W.E., Seibert K., Zhang Y., Zweifel B.S., Reitz D.B. Novel terphenyls as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agents. J. Med. Chem. 1996, 39:1846-1856.
6. The United States Pharmacopeia, XXIII, Rockville, MD, 1995, pp. 1053-1055.
7. British Pharmacopeia, Her Majesty's Stationery Office, London, UK, 1988.
8. Martin M.J., Pablos F., Gonzales A.G. Simultaneous determination of caffeine and non-steroidal anti-inflammatory drugs in pharmaceutical formulations and blood plasma by reversed-phase HPLC from linear gradient elution. Talanta 1999, 49:453-459.
9. Perez-Ruiz T., Martinez-Lozano C., Tomas V., Carpena J. Selective determination of naproxen in the presence of nonsteroidal anti-inflammatory drugs in serum and urine samples using room temperature liquid phosphorimetry. J. Pharm. Biomed. Anal. 1998, 17:719-724.
10. Hirai T., Matsumoto S., Kishi I. Simultaneous analysis of several non-steroidal anti-inflammatory drugs in human urine by high-performance liquid chromatography with normal solid-phase extraction. J. Chromatogr. B. Biomed. Sci. Appl. 1997, 692:375-388.
11. Karidas T., Avgerinos A., Malamataris S. Extractionless HPLC method for the determination of naproxen in human plasma and urine. Anal. Lett. 1993, 26:2341-2348.
12. Sadecka J., Cakrt M., Hercegova A., Polonsky J., Skacani I. Determination of ibuprofen and naproxen in tablets. J. Pharm. Biomed. Anal. 2001, 25:881-891.
13. Ekpe A., Tong J.H., Rodriguez L. High-performance liquid chromatographic method development and validation for the simultaneous quantitation of naproxen sodium and pseudoephedrine hydrochloride impurities. J. Chromatogr. Sci. 2001, 39:81-86.
14. Mikami E., Goto T., Ohno T., Matsumoto H., Nishida N. Simultaneous analysis of naproxen, nabumetone and its major metabolite 6-methoxy-2-naphthylacetic acid in pharmaceuticals and human urine by high-performance liquid chromatography. J. Pharm. Biomed. Anal. 2000, 23:917-925.
15. Impurities in New Drug Substances Q3A(R2), ICH Harmonised Tripartite Guidelines, 25 October, 2006.
16. Nussbaum M.A., Baertschi S.W., Jansen P.J. Determination of relative UV response factors for HPLC by use of a chemiluminescent nitrogen-specific detector. J. Pharm. Biomed. Anal. 2002, 27:983-993.
17. Sun P., Wang X., Alquier L., Maryanoff C.A. Determination of relative response factors of impurities in paclitaxel with high performance liquid chromatography equipped with ultraviolet and charged aerosol detectors. J. Chromatogr. 2008, 1177:87-91.
18. Webster G.K., Marsden I., Pommerening C.A., Tyrakowski C.M., Tobias B. Determination of relative response factors for chromatographic investigations, using NMR spectrometry. J. Pharm. Biomed. Anal. 2009, 49:1261-1265.